Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Resolution of inflammation during multiple sclerosis
Florian Ruiz, Solenne Vigne, Caroline Pot
Seminars in Immunopathology (2019) Vol. 41, Iss. 6, pp. 711-726
Open Access | Times Cited: 108

Showing 1-25 of 108 citing articles:

Bruton tyrosine kinase inhibitors for multiple sclerosis
Julia Krämer, Amit Bar‐Or, Timothy J. Turner, et al.
Nature Reviews Neurology (2023) Vol. 19, Iss. 5, pp. 289-304
Open Access | Times Cited: 99
Relationship between inflammation and oxidative stress and its effect on multiple sclerosis
Elsy Janeth Ramos-González, Oscar Kurt Bitzer-Quintero, Genaro Gabriel Ortíz, et al.
Neurología (English Edition) (2024) Vol. 39, Iss. 3, pp. 292-301
Open Access | Times Cited: 25
Targeting CSF-1R represents an effective strategy in modulating inflammatory diseases
Caigui Xiang, Heng Li, Wei Tang
Pharmacological Research (2022) Vol. 187, pp. 106566-106566
Open Access | Times Cited: 49
Sphingosine 1-phosphate receptor, a new therapeutic direction in different diseases
Hongyu Chen, Junmin Wang, Caiyun Zhang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113341-113341
Open Access | Times Cited: 45
Administration of Maresin-1 ameliorates the physiopathology of experimental autoimmune encephalomyelitis
Alba Sánchez‐Fernández, Stéphanie Zandee, Mauricio Mastrogiovanni, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 43
Regulatory Cells in Multiple Sclerosis: From Blood to Brain
Leticia Calahorra, Celia Camacho-Toledano, Mari Paz Serrano‐Regal, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 335-335
Open Access | Times Cited: 39
Lactate metabolism in neurodegenerative diseases
Chaoguang Yang, Rui‐Yuan Pan, Fangxia Guan, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 1, pp. 69-74
Open Access | Times Cited: 37
The Use of Stem Cells as a Potential Treatment Method for Selected Neurodegenerative Diseases: Review
Elżbieta Cecerska‐Heryć, Maja Pękała, Natalia Serwin, et al.
Cellular and Molecular Neurobiology (2023) Vol. 43, Iss. 6, pp. 2643-2673
Open Access | Times Cited: 36
Boswellic Acids: A Critical Appraisal of Their Therapeutic and Nutritional Benefits in Chronic Inflammatory Diseases
Neeta Solanki, Gaurav Gupta, Dinesh Kumar Chellappan, et al.
Endocrine Metabolic & Immune Disorders - Drug Targets (2023) Vol. 24, Iss. 1, pp. 116-129
Closed Access | Times Cited: 27
Astrocytic Chitinase‐3‐like protein 1 in neurological diseases: Potential roles and future perspectives
Fei Li, An Liu, Ming Zhao, et al.
Journal of Neurochemistry (2023) Vol. 165, Iss. 6, pp. 772-790
Open Access | Times Cited: 25
Relationship between inflammation and oxidative stress and its effect on multiple sclerosis
Elsy Janeth Ramos-González, Oscar Kurt Bitzer-Quintero, Genaro Gabriel Ortíz, et al.
Neurología (2021) Vol. 39, Iss. 3, pp. 292-301
Open Access | Times Cited: 43
A novel fatty acid-binding protein 5 and 7 inhibitor ameliorates oligodendrocyte injury in multiple sclerosis mouse models
An Cheng, Wenbin Jia, K. Kawahata, et al.
EBioMedicine (2021) Vol. 72, pp. 103582-103582
Open Access | Times Cited: 41
Pyroptosis in neurodegenerative diseases: from bench to bedside
Kejia Wu, Wan-rong Wang, Qian-hui Cheng, et al.
Cell Biology and Toxicology (2023) Vol. 39, Iss. 6, pp. 2467-2499
Closed Access | Times Cited: 18
The Impact of Social Cognition Deficits on Quality of Life in Multiple Sclerosis: A Scoping Review
Giulia Marafioti, Davide Cardile, Laura Culicetto, et al.
Brain Sciences (2024) Vol. 14, Iss. 7, pp. 691-691
Open Access | Times Cited: 6
Resolvin D1 protects against sepsis‐induced cardiac injury in mice
Menglong Wang, Menglin Liu, Jishou Zhang, et al.
BioFactors (2020) Vol. 46, Iss. 5, pp. 766-776
Closed Access | Times Cited: 41
Emerging Biomarkers of Multiple Sclerosis in the Blood and the CSF: A Focus on Neurofilaments and Therapeutic Considerations
Tamás Biernacki, Zsófia Kokas, Dániel Sandi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3383-3383
Open Access | Times Cited: 25
Synapse Dysfunctions in Multiple Sclerosis
Karin Schwarz, Frank Schmitz
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1639-1639
Open Access | Times Cited: 15
The role of systemic ımmune ınflammatory ındex in showing active lesion ın patients with multiple sclerosis
Şeyda Figül Gökçe, Asli Bolayır, Burhanettin Çiğdem, et al.
BMC Neurology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Re-establishing immune tolerance in multiple sclerosis: focusing on novel mechanisms of mesenchymal stem cell regulation of Th17/Treg balance
Huiru Hu, Hui Li, Ruoyu Li, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Immuno-metabolic impact of the multiple sclerosis patients’ sera on endothelial cells of the blood-brain barrier
Madeeha H. Sheikh, Siân M. Henson, Rodrigo Azevedo Loiola, et al.
Journal of Neuroinflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 33
The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis
Angela Dziedzic, Joanna Saluk, Elżbieta Miller, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1804-1804
Open Access | Times Cited: 30
Mechanism of Anti-Inflammatory and Antibacterial Effects of QingXiaoWuWei Decoction Based on Network Pharmacology, Molecular Docking and In Vitro Experiments
Qian Zhang, Xue Li, Jun Li, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 28
Comparative targeted lipidomics between serum and cerebrospinal fluid of multiple sclerosis patients shows sex and age-specific differences of endocannabinoids and glucocorticoids
Philip Meier, Sandra Glasmacher, Anke Salmen, et al.
Acta Neuropathologica Communications (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 4
Spatiotemporal profile of an optimal host response to virus infection in the primate central nervous system
Olga A. Maximova, Sarah L. Anzick, Daniel E. Sturdevant, et al.
PLoS Pathogens (2025) Vol. 21, Iss. 1, pp. e1012530-e1012530
Open Access
Annexin A1 in neurological disorders: Neuroprotection and glial modulation
Luiz Philipe de Souza Ferreira, Rafael André da Silva, Pâmela Pacassa Borges, et al.
Pharmacology & Therapeutics (2025), pp. 108809-108809
Closed Access
Page 1 - Next Page

Scroll to top